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Aim To evaluate shear-wave elastographic (SWE) and relat-
ed gray-scale features of pure invasive lobular breast carci-
noma (ILC) and compare them with invasive ductal breast 
cancers (IDC).
Methods Quantitative SWE features of mean (El-mean), 
maximum (El-max), minimum (El-min) elasticity values of 
the stiffest portion of the mass, and lesion-to-fat elasticity 
ratio (E-ratio) were measured in 40 patients with pure ILC 
and compared with 75 patients with IDC. Qualitative gray-
scale features of lesion size, echogenicity, orientation, and 
presence of distal shadowing were determined and com-
pared between the groups.
Results ILC were significantly larger than IDC (P = 0.008) 
and exhibited significantly higher El-max (P = 0.015) and 
higher El-mean (P = 0.008) than IDC. ILC were significantly 
more often horizontally oriented, while IDC were signifi-
cantly more often vertically oriented (P < 0.001); ILC were 
significantly more often hyperechoic than IDC (P < 0.001). 
Differences in stiffness between ILC and IDC determined 
by quantitative SWE parameters were present only in small 
tumors (≤1.5 cm in size), ie, small ILC had significantly 
higher El-max (P = 0.030), El-mean (P = 0.014), and El-min 
(P = 0.045) than small IDC, while tumors larger than 1.5 cm 
had almost equal stiffness, without significant differences 
between the groups.
Conclusion Specific histopathologic features of ILC are 
translated into their qualitative sonographic and quantita-
tive sonoelastographic appearance, with higher stiffness of 
small ILC compared to small IDC. Gray-scale and sonoelas-
tographic features may help in diagnosing ILC.
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Invasive ductal cancer (IDC) is the most common breast 
cancer, while invasive lobular cancer (ILC) is the second 
most common and accounts for 6%-12% of breast cancers 
(1-3). ILC differs considerably from IDC by having a unique 
pathological growth pattern, the so called Indian-file pat-
tern, with sheets of single-cell layers growing along the 
Cooper ligaments, ductuli, and other breast structures, re-
sembling a spiderweb that diffusely spreads in the breast, 
producing minor desmoplastic reaction (4,5). This spider-
web-like growth is reflected in imaging features of ILC, as 
well as in its clinical presentation (6). IDC usually clinically 
manifests as a firm lump, while ILC usually manifests as a 
palpable thickening and skin or nipple retraction (3,5). ILC 
has increased tendency for multifocality and multicentric-
ity, a higher risk of bilateral breast cancer (20%-29%), and 
older age at onset (7,8). Lymph node metastases are less 
common in ILC than in IDC of equal size, because ILC tu-
mor cells lack cellular atypia and often have low mitotic 
rate (9). ILC has the propensity to metastasize to the chest, 
peritoneum, retroperitoneum, and pelvis (10).
Because of its growth pattern of mass infiltrating sur-
rounding tissues, IDC is much more easily detected than 
ILC also on mammography. ILC has higher false-negative 
mammographic rates than IDC, since ILC may be invisible 
or may have quite low mammographic density, and mi-
crocalcifications are uncommon (6,11). Due to the higher 
propensity for multicentric and bilateral lesions, it is gener-
ally considered that patients with ILC should be referred 
to preoperative breast MRI, the best imaging modality to 
evaluate the tumor extent, while the benefit for preopera-
tive MRI in IDC has not yet been proven (12,13). Fine-nee-
dle aspiration is not as sensitive for the diagnosis of ILC as it 
is for IDC, and core-biopsy should be performed when ILC 
is suspected, even in cases of palpable lesions (14,15). ILC 
is associated more often than IDC with positive margins on 
surgical excision and is more often treated with mastec-
tomy, because of the large size at diagnosis and underesti-
mation of tumor extent with conventional imaging (16).
Ultrasound of the breast is widely used in the diagnosis of 
breast cancer, usually after mammography, and most im-
age-guided core biopsies of breast lesions are routinely 
performed under the sonographic guidance (17,18). Ul-
trasound is highly operator-dependent, much more than 
mammography or MRI. The quality of ultrasonic equip-
ment and transducers is variable, suboptimal examinations 
are common, and interobserver variability is high; sensitiv-
ity of ultrasound in detection of ILC is reported in the range 
of 68%-88% (6,12,19).
Sonoelastography is a relatively new ultrasonographic 
method, which may help in the detection and differentia-
tion of benign and malignant breast lesions (18,20). Strain 
elastography allows qualitative estimation of the breast le-
sion stiffness, while shear-wave elastography (SWE) allows 
quantification of lesion stiffness in kilopascals (kPa) (18). 
Multicentric studies found that SWE features can help dis-
criminate breast cancers and benign breast lesions, and 
breast cancers among themselves (20-22). It was also 
shown that some IDC, like triple negative breast cancers, 
differ in their stiffness compared to other IDC (23). Stud-
ies evaluating some SWE features of invasive cancers were 
done in a small number of patients with ILC, but to the 
best of our knowledge none so far has provided values 
specific for a larger, homogeneous group of patients with 
pure ILC (24,25).
The aim of this single-center study was to evaluate and es-
tablish SWE and related conventional sonographic features 
of pure ILC of the breast in a group of 40 patients, and to 
compare these features with the most common invasive 
breast cancer, IDC. SWE features within ILC group were also 
correlated with tumor size, extent, histologic grade, and 
the presence of nodal metastases.
MaTErIaLs anD METhoDs
The design of this single-center study was retrospective. 
SWE and related sonographic features were reviewed in 40 
female patients with histopathologically confirmed pure 
ILC, diagnosed in the period of five years (2011-2015) in 
our department. The same features were analyzed in 75 
patients diagnosed with IDC in the period of 18 months 
(2014 and 2015). The final histopathological diagnosis af-
ter surgery was available for all patients. For ILC patients, 
histopathologic findings were studied for the presence of 
multifocal disease, angioinvasion, bilateral disease, axillary 
lymph node metastases, histologic tumor grade, human 
epidermal growth factor receptor 2 (HER2), and hormone 
receptor status. Only patients with pure ILC and pure IDC 
with our without in-situ component were included in the 
study, while the patients with mixed ductulolobular can-
cers were excluded.
All patients underwent the SWE examination on the same 
state-of-art ultrasound scanner Aixplorer (Supersonic Imag-
ine, Aix en Provence, France), with the same linear high-
frequency 4-15 MHz transducer. All ultrasonographic 
examinations were performed in the course of the reg-
ular diagnostic process and images were taken im-
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mediately prior to the ultrasound-guided core biopsy and 
stored at the hard disk of the ultrasound scanner. Imaging 
protocol was standardized and all examinations were per-
formed by the single experienced breast radiologist with 
25 years experience in breast ultrasound examinations (the 
first author). The established examination technique was 
used, without manual compression, with careful electronic 
focusing of the lesion, and analysis and measurement on 
B-mode and elastographic image, using always the same 
preset. The stiffness of the lesion was measured by using 
the built-in quantification region of interest (ROI) of the sys-
tem (Q-Box). This is a quantification tool that measures tis-
sue stiffness in kilopascals. ROI size of 2 mm was used in all 
measurements, placed by the investigator over the stiffest 
part of the lesion, or at the edge, or within 1-2 mm adja-
cent to the lesion, at the stiffest part. The stiffest part of the 
lesion was selected based on the color of the lesion that 
correlates with kilopascals, and several measurements were 
performed in the red or bright parts of the lesion, with the 
highest values recorded. A second ROI of the same size was 
placed in the fatty tissue of the breast to measure the ratio 
between mean elasticity values in the lesion and in the fat, 
the so called elasticity ratio (E ratio).
After generating and capturing a shear wave with ultra-
fast imaging, the scanner quantifies shear-wave propaga-
tion speed and provides the real time SWE color map. Tis-
sue elasticity is derived from the shear-wave propagation 
speed on the basis of Young’s modulus formula, and the 
local tissue elasticity values in kilopascals are displayed on 
the image in a color map along with conventional B-mode 
image (20,22). The breast preset in the penetration mode 
was used for all measurements, with the highest stiffness 
set at ≥180 kPa (7.7 m/s). Quantitative SWE features were 
measured: mean (El mean), maximum (El max), and mini-
mum (El min) elasticity value of the stiffest portion of the 
mass, and E ratio (20,22).
Before elastographic measurements, the related sono-
graphic features on the image were analyzed. Only the larg-
est mass/lesion (index lesion) detected on ultrasound per 
patient was measured, its orientation estimated, and the 
presence of distal acoustic phenomena (shadowing or en-
hancement) noted, after which SWE analysis of the lesion 
was performed. On the gray scale image, the longest diam-
eter of the lesion was measured, and qualitative features, 
such as echogenicity, orientation of the lesion, and the 
presence of distal acoustic phenomena, were analyzed. 
Regarding echogenicity, the lesions were categorized 
as hypoechoic (if the whole or majority of the le-
sion had lower echogenicity than the breast parenchyma) 
or hyperechoic (if the lesion completely or predominantly 
had higher echogenicity than the parenchyma). Regarding 
the orientation, lesions were categorized as vertically ori-
ented (when anteroposterior diameter was larger or equal 
to laterolateral diameter) or horizontally oriented (when 
laterolateral diameter was larger than anteroposterior di-
ameters). Also, the presence or the absence of the distal 
acoustic shadowing was noted, while none of the patients 
exhibited distal acoustic enhancement. The size estimat-
ed by ultrasound was used for statistical analysis, because 
the study evaluated the sonographic appearance of breast 
cancers. In case of multifocal or bilateral cancers, common 
in ILC, only the largest, single index lesion per patient was 
used for SWE evaluation and comparisons between the 
patient groups. Virtually all lesions had sonographically ir-
regular borders. All images were stored digitally.
Mastectomy or breast conserving surgery was performed 
for all breast cancers, and the histological type of invasive 
cancer was available for all patients, determined on the 
basis of surgically excised specimens. For invasive lobu-
lar cancers, data were analyzed for each patient regarding 
the histological grade, determined using the method of 
Elston and Ellis, lymph node status, presence of multifo-
cal or bilateral disease, and lymph node status (26). Estro-
gen receptor (ER), progesterone receptor (PR), and HER2 
status were evaluated by immunohistochemistry staining 
methods according to American Society of Clinical Oncol-
ogy (ASCO) and College of American Pathologists (CAP) 
guideline recommendations for HER2 and ER/PR testing. 
E-cadherin was tested in all patients (27). Sentinel lymph-
node biopsy was performed in all patients, followed by ax-
illary dissection in positive cases. Informed consent for ul-
trasound-guided core biopsy, prior to which sonographic 
and elastographic analysis was performed, was obtained 
from patients according to the institutional rules. The study 
was approved by the institutional ethics committee.
statistical analysis
Frequency distributions of selected patients and tumor 
characteristics were determined for all women. Quantita-
tive variables were tested for normality of the distribution 
with Kolmogorov-Smirnov test. Differences in lesion size 
and depth; El mean, El max, and El min values; and E-ratios 
between patients with IDC and ILC were evaluated using 
the t test. Differences in sonographic features; echogenic-
ity, orientation of the lesion, presence of distal acoustic 
phenomena; and tumor characteristics were evaluated us-
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ing the Pearson χ2 square exact test. The receiver operating 
characteristic (ROC) curve analysis was expressed as area 
under curve (AUC) with its 95% confidence intervals (CI), 
and the curves were constructed for the El mean, El max, 
and El min elasticity values; and E-ratios. Diagnostic effica-
cy for elastographic values was assessed through sensitivi-
ty and specificity at cut-off points. All statistical calculations 
were performed using STATA/IC ver.11.1. (Stata Statistical 
Software: Release 11. StataCorp LP, College Station, TX, 
USA). Results of statistical tests with P values lower than 
0.05 were considered significant.
rEsuLTs
The mean age of the patients in the ILC group was 
62.2 ± 11.61 years (range, 41 to 91), and of the patients in 
the IDC group was 60.73 ± 12.61 years (range, 31 to 81). 
There was no significant difference between the groups in 
age (P = 0.540).
The mean size of index lesions measured by ultrasound 
was significantly larger in the ILC than in the IDC group 
(2.25 cm ±1.30 vs 1.55 ± 0.90, P = 0.008). Significant differ-
ences were also observed in orientation and echogenic-
ity of lesions. Significantly more lesions from the ILC group 
(31 out of 40, 77.5%) had horizontal orientation (P = 0.001), 
and significantly more lesions from the IDC group (43 of 
75, 57.3%) had vertical orientation (P = 0.024). Significantly 
more lesions from the IDC group were hypoechoic (69 of 
75, 92.0%), and in the ILC group 13 of 40 lesions (32.5%) 
were hyperechoic and 27 of 40 (67.5%) were hypoechoic 
(P = 0.001). There was no significant difference in the pres-
ence of distal acoustic shadowing, 58.7% (44 of 75) of IDC 
and 57.5% (23 of 40) of ILC (P = 0.900).
Qualitative analysis of SWE features demonstrated sig-
nificant differences in the El max of the stiffest portion of 
the mass of ILC vs IDC. ILC group had significantly high-
er El max than IDC group (mean value 210.61 ± 35.47 kPa 
vs 191.64 ± 41.25 kPa, P = 0.015) (Table 1). ILC group also 
had higher El mean than IDC group (180.41 ± 27.96 kPa 
vs 162.20 ± 37.46 kPa, P = 0.008). The differences in E min 
and in the lesion-to-fat elasticity ratio were not significant 
(Table 1).
The ability of the measured quantitative SWE values to dis-
criminate between IDC and ILC was analyzed using the 
ROC curve analysis. The two groups could be distinguished 
on the basis of SWE values of El max (AUC 0.654, 95% CI 
0.552-0.757), El mean (AUC 0.674, 95% CI 0.572-0.775), 
El min (AUC 0.620, 95% CI 0.510-0.729), and E ratio (AUC 
0.569, 95% CI 0.454-0.684). Discriminatory ability of El max, 
El mean, El min, and E ratio between ILC and IDC patients 
using the sensitivity and specificity at the specified cut-off 
point according to ROC curves is presented in Figure 1.
TaBLE 1. Elastographic and related sonographic findings in 
patients with invasive lobular carcinoma (ILC) and invasive 
ductal carcinoma (IDC)
 
Characteristics
ILC (n = 40) 
n (%)
IDC (n = 75) 
n (%)
orientation:*
horizontal  30 (75.0)  32 (42.7)
vertical  10 (25.0)  43 (57.3)
Echogenicity:*
hypoechoic  27 (67.5)  69 (92)
hyperechoic  13 (32.5)   6 (8)
acoustic shadowing:
present  23 (57.5)  44 (58.7)
absent  17 (42.5)  31 (41.3)
size in cm*†   2.25 ± 1.30   1.55 ± 0.90
Maximum elasticity 
in kilopascals*
210.61 ± 35.47 191.64 ± 41.25
Mean elasticity 
in kilopascals*
180.41 ± 27.06 162.20 ± 37.46
Minimum elasticity 
in kilopascals
135.35 ± 32.36 123.48 ± 32.69
Lesion-to-fat ratio of elasticity   8.36 ± 4.19   7.22 ± 3.09
*P < 0.050, χ2 test, t test.
†mean ± standard deviation.
TaBLE 2. Elastographic findings of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) stratified by 
sonographic tumor size ≤1.5 cm and >1.5 cm
ILC≤1.5 cm IDC≤1.5 cm ILC>1.5 cm IDC>1.5 cm
number of patients (%)  13 (32.5)  47 (62.7)  27 (67.5)  28 (37.3)
shear-wave elastographic features:†
maximum elasticity in kilopascals* 198.33 ± 36.73* 176.22 ± 30.16* 216.53 ± 33.96 218.26 ± 45.45
mean elasticity in kilopascals* 175.31 ± 31.05* 149.44 ± 33.04* 182.86 ± 25.19 183.90 ± 35.67
minimum elasticity in kilopascals* 131.23 ± 21.27* 113.81 ± 28.38* 137.33 ± 36.74 139.46 ± 34.08
lesion-to-fat ratio of elasticity   8.22 ± 4.75   6.53 ± 2.29   8.42 ± 3.99   8.45 ± 3.93
*P < 0.050, t test.
†mean ± standard deviation.
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22 of 40 (55%) index ILC lesions and 17 of 75 IDC (22.7%) 
lesions were larger than 2 cm. 15 of 40 (37.5%) ILC lesions 
and 42 of 75 IDC lesions (56.0%) were between 1-2 cm in 
size. Only 3 of 40 ILC lesions (7.5%) and 16 of 75 IDC lesions 
(21.3%) were smaller than 1 cm. If the cut-of value of 1.5 
cm is used, 13 of 40 ILC (32.5%) and 47 of 75 IDC (62.7%) 
lesions were ≤1.5 cm, which represents a significant differ-
ence (P = 0.002).
Due to the differences in index lesion sonographic size 
distribution between groups (P = 0.008), we stratified our 
analysis of SWE features by the tumor size (Table 2). Among 
smaller tumors, with the index lesion size ≤1.5 cm, the El 
max, El mean, and El min values in ILC group were signifi-
cantly higher than in IDC group (El max 198.33 ± 36.73 kPa 
vs 176.22 ± 30.16 kPa, P = 0.030; El mean 175.31 ± 31.05 kPa 
vs 149.44 ± 33.04 kPa, P = 0.014; El min 131.23 ± 21.27 kPa 
vs 113.81 ± 28.38 kPa, P = 0.045), while differences in E-ra-
tio were not significant (8.22 vs 6.53, P = 0.074). However, 
in the group of tumors larger than 1.5 cm, no significant 
differences were observed, and El max, El mean, and El min 
were even slightly higher in the IDC group.
All patients with ILC had ER-positive and HER 2-negative 
cancers, 29 patients (72.5%) had histopathologic grade 2, 
and 11 patients (27.5%) had grade 3 ILC. 6 patients (15%) 
had bilateral ILC, and all bilateral cancers were grade 2. 
Multifocal breast disease was found in 27 patients (67.5%), 
metastatic axillary lymph nodes in 19 patients (47.5%), and 
angioinvasion in 14 patients (35%).
Among 13 ILC patients with tumor size ≤1.5 cm (32.5%), 
multifocal disease was observed on histopatological ex-
amination in 8 patients (61.5%), which is almost the same 
as in 27 patients with ILC index lesion larger than 1.5 cm 
(70.4%) (19/27). Even though the group of patients with 
ILC≤1.5 cm was small and consisted of only 13 patients, 
a significant difference in El max was observed between 
multifocal and unifocal small tumors (238.1 ± 42.5 kPa vs 
180.1 ± 20.1; P = 0.011).
FIGurE 1. Discriminatory ability of maximum elasticity value of the stiffest portion of mass (El max), mean elasticity value of the 
stiffest portion of mass (El mean), minimum elasticity value of the stiffest portion of mass (El min), and lesion-to-fat elasticity ratio (E 
ratio) between invasive lobular breast cancer (ILC) and invasive ductal breast cancers (IDC) patients according to receiver operating 
characteristic (roC) curves. Diagnostic efficacy for those values was assessed using the sensitivity and specificity at the specified cut-
off point. roC curve analyses, P values <0.050 were considered significant.
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3/13 patients with small ILC also had axillary lymph node 
metastases, and the same proportion had angioinvasion 
(23.1%), while 16/27 patients with larger ILC lesions had 
axillary metastases (59.3%) and 11/27 had angioinvasion 
(40.7%). Bilateral disease was found in 6/40 ILC patents 
(15%); 4 of whom had tumor size ≤1.5 cm. Although ILC 
patients had higher values in cancers with higher tumor 
grade, and cancers with axillary metastasis and angioinva-
sion, no significant difference were found. The examples 
of the small IDC and small ILC with quantitative SWE mea-
surements are presented in Figures 2 and 3.
DIsCussIon
It was reported that due to its specific diffusely infiltrating 
growth pattern ILC was usually larger when detected com-
pared to IDC, and our study is in accordance with these re-
ports (19). The differences in histopathological features are 
reflected in clinical and imaging manifestations of ILC and 
IDC (3,5,6,11). We showed differences in sonographic pre-
sentation and in sonoelastographic features.-ILC exhibited 
greater stiffness. However, the difference was pronounced 
only in tumors with the size ≤1.5 cm, while in larger tu-
mors, which are stiffer than small tumors, SWE stiffness pa-
rameters were similar in ILC and IDC.
A study that evaluated the ability of SWE to differentiate 
between benign and malignant breast tumors found that 
it improved the specificity of breast ultrasound (20). In a 
recently published large multicentric study by Berg et al 
(21), performed in 16 centers in Europe and the USA, the 
mean El max of 468 invasive cancers, in which IDC and ILC 
were not separated, and in which the mean diameter of 
invasive cancer was 15 ± 8.3 mm, was 180 kPa (21). In our 
study, IDC had higher overall stiffness, with the mean El 
max of 191.64 kPa but with the slightly larger mean tumor 
size of 15.5 ± 9.0 mm. When we separately analyzed lesions 
below the size of 1.5 cm in our study, the stiffness of IDC 
was 176.22 kPa and of ILC 198.33 kPa. Since the propor-
tion of ILC among invasive cancers encountered in clini-
cal practice is below 10%, our results are not very different 
compared to the study by Berg et al (21). In the study of 
Chang et al, 337 invasive breast cancers were evaluated by 
five radiologists. The mean size of invasive tumor was quite 
high, 2.2 ± 1.1 cm, and the El mean was 146.8 ± 57.0 kPa. For 
16 ILC the El mean was 149.0 ± 51.7 kPa, which was almost 
the same as for IDC (147.9 ± 57.04 kPa) (25). This study, with 
much larger cancers than in our or Berg’s study, neither 
provided E max values nor performed the stratification by 
size. Therefore, their values cannot be compared precisely 
to ours. The values of El mean in the Chang’s study were 
lower than in our study, despite the larger mean tumor 
size, ie, they were similar to El mean values observed in the 
group of small IDC in our study, while larger tumors in our 
study had higher El mean values.
All sonographic examinations, and especially sonoe-
lastographic examinations, are very operator-de-
FIGurE 2. small, hyperechoic invasive lobular breast cancer 
(ILC), with high stiffness and high values of El max, El mean, 
and El min. abbreviations are explained in Figure 1.
FIGurE 3. small, hypoechoic invasive ductal breast cancers 
(IDC), with low stiffness values of El max, El mean, and El min. 
abbreviations are explained in Figure 1.
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pendent. In this respect, the advantage of our study was 
that it was performed by a single experienced examiner 
on a single high-quality ultrasound scanner, with stand-
ardized examination protocol. It was demonstrated, like 
in other studies, that the size of the measured tumor af-
fected quantitative stiffness values estimated by SWE, so 
that the larger cancers were stiffer than smaller cancers 
(21,22,24,25). To the best of our knowledge, our group of 
patients is the largest group of patients with histopatho-
logically pure ILC analyzed so far with SWE. The fact that 
ILC lesions observed on ultrasound are significantly larg-
er compared to IDC reflects the clinical practice in which 
ILC are often found in the advanced stage. Most IDC that 
we examined were small and were referred to ultrasound 
after mammography performed in women with no clini-
cal symptoms within the scope of the national mammo-
graphic screening program, that is, conducted in the age 
group of 50-69 years. Mammographic screening allows 
the diagnosis of small, clinically asymptomatic invasive 
cancers, which are most often IDC. ILC is often misdiag-
nosed at mammography in an early stage, shrinking breast 
mammographic phenomenon may be seen, or the mass is 
visible only on CC projections (28-30), and the ultrasono-
graphic correlate of mammographically detected lesions is 
apparently larger, as demonstrated in our study, in which 
67.5% of ILC were larger than 1.5 cm, while only 37.3% of 
IDC were larger than 1.5 cm.
Ultrasonographically measured larger ILC and IDC lesions in 
our study apparently did not differ in elastographically esti-
mated stiffness. However smaller lesions differed consider-
ably, and small ILC had significantly higher stiffness, which, 
to the best our knowledge, had not been reported so far. 
In order to determine why small ILC are stiffer than small 
IDC we correlated ultrasound findings with the histopatho-
logic findings of resected breast specimens of ILC, since ILC 
is known to have the propensity for multifocality and bi-
laterality (3,7,8). Even though the sonographic appearance 
was of the small mass size, 8 of 13 small ILCs had multifocal 
disease in the breast on histopathology (61.5%), 4 had bilat-
eral disease, 3 had angioinvasion, and 3 had axillary lymph 
node metastases. Altogether, 6 of 40 patients (15%) in our 
patient group had bilateral ILC, which is fewer compared to 
20%-29% patients in other studies (7,8). Ultrasonographic 
measurement of the largest visible mass and elastographic 
evaluation of stiffness do not seem to be good markers for 
evaluation of the disease extent in ILC, as is the case in IDC. 
This is presumably the consequence of the “spiderweb” 
growth pattern of ILC, which cannot be well estimated 
by gray-scale ultrasound. Among small ILC, stiffness 
parameters were higher in multifocal tumors than in unifo-
cal tumors, and although the group is very small the differ-
ence in E max reached the level of significance. Therefore, 
SWE evaluation may be better than gray-scale ultrasound, 
since it seems to better reflect the disease extent. Studies 
on larger groups of patients are needed to confirm this ob-
servation. It seems reasonable to conclude that ILC with 
sonographically small index tumor might be larger if they 
have higher stiffness. This does not happen in the small IDC, 
which do not exhibit the “spiderweb” growth pattern, but 
grow as a single focal locally infiltrative mass.
We observed some gray-scale differences between ILC and 
IDC, which may be useful in daily clinical imaging practice. 
ILC were significantly more often horizontally oriented 
than IDC, and had significantly higher proportion of hyper-
echoic lesions. We observed a low proportion of vertical 
lesions among ILC (25%), similar to Cawson et al (24%) (31). 
In our study, ILC and IDC did not differ in the proportion of 
acoustic shadowing.
Ultrasound is an established imaging modality for detec-
tion and differentiation of breast lesions, usually performed 
to further evaluate suspicious or equivocal mammograph-
ic findings and to perform ultrasound-guided biopsy of 
suspicious breast lesions. The clinical significance of ob-
served differences between ILC and IDC in our study is rel-
atively minor, since all lesions with morphologically suspi-
cious features for invasive cancers need to be subjected to 
image-guided core biopsy. ILC need to be referred to pre-
operative contrast-enhanced breast MRI, the best method 
to assess tumor extent, multifocality, and bilaterality. The 
presence of some of the described gray scale features and 
very stiff lesions on SWE may indicate to sonologists that 
the lesion with morphologic sonographic features of inva-
sive breast cancer might not be the common IDC, but the 
less common ILC.
The limitation of this study is the relatively small number of 
patients with ILC. Within the ILC group, we could not dem-
onstrate that stiffness values correlated with histological 
cancer grade, axillary lymph node involvement, or the pres-
ence of angioinvasion, which was demonstrated for IDC 
in larger patient groups (21). However, it is hard to collect 
higher numbers of patients with pure ILC in a single center, 
and it took as five years to collect the group of 40 of pa-
tients with all imaging features needed for the study. ILC is 
a relatively rare type of cancer, seen in fewer than 10% of 
invasive cancers diagnosed in our institution, and not all pa-
tients referred to surgery in our institution were subjected 
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to core biopsy and preoperative ultrasound examination in 
our department. Another limitation is that the interobsev-
er variability was not studied, since only a single examiner 
performed all the measurements. However, this setting has 
ensured the uniform examination technique. Elastographic 
measurements and analysis are prone to high subjectivity 
of the examiner. The fact that only the highest values of El 
max, El mean, and El min were recorded per patient may not 
reflect the accurate stiffness of lesions, and maybe several 
measurements in different parts of lesions, with collection 
of values in different part of tumors, would render higher 
accuracy. However, the study reflects the usual clinical work-
flow, in which in a reasonable time frame there needs to be 
assessed whether a lesion has a low or high stiffness to allow 
further sonographic management.
As a conclusion, specific histopathologic features of in-
vasive lobular carcinoma seem to be translated into their 
qualitative sonographic and quantitative sonoelastograph-
ic appearance. Sonographically small ILC, with the size ≤1.5 
cm, seem to be stiffer than IDC of the same size, while larg-
er tumors exhibit no difference in elastographic parame-
ters. Our results indicate that sonographically small ILC le-
sions with higher stiffness estimated by SWE-have higher 
likelihood to be multifocal compared to small ILC lesions 
with lower stiffness. The knowledge about gray-scale and 
sonoelastographic features more commonly observed in 
ILC may help radiologists in diagnosing this relatively un-
common type of invasive cancer, with distinct histopatho-
logic features and different imaging and clinical appear-
ance compared to common IDC.
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